Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Italy / NCT07175610
Starting soon Observational

LUpus Eritematoso Sistemico NETwork and Registry

NCT07175610 · tracked via the Priya Life Science Italy tracker
Sponsor
Società Italiana di Allergologia, Asma e Immunologia Clinica
Phase
Observational
Started
2025-09-30
Last updated
2025-09-16

Condition(s) studied

Systemic Lupus Erythematous (SLE)

Study summary

The LUNET Registry is intended to serve as a comprehensive primary data source, capturing real-world longitudinal clinical information, and the heterogeneity of patient presentations that are often underrepresented in traditional clinical trials. Ultimately, the LUNET Registry will help to optimize SLE management in routine clinical practice by enabling the compilation of real-world evidence to inform clinical decision-making and health policy. Patients will be enrolled by secondary and tertiary care centres for SLE across Italy in a real-world clinical set-up.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * age ≥ 18 years; * confirmed SLE diagnosis according to the SLICC 2012 and/or ACR/EULAR 2019 classification criteria; * provision of signed written informed consent prior to participation Exclusion Criteria: \-

Primary outcome measure(s)

  • Remission — Every year to ten year
    Number of patients who achieved complete clinical remission or low disease activity
  • Disease activity — Every year to ten year
    Changes in disease activity (SLEDAI-2k)

Trial sites (16)

FacilityCityRegionStatus
SOD Clinica Medica, Dip. Medicina Interna- Ospedali Riuniti Marche-AOU delle Marche Ancona Italy
Medicina Interna Universitaria (Guido Baccelli) Azienda Ospedaliera Policlinico Consorziale Bari Italy
U.O. di Medicina, Ospedale Civile "Santa Maria della Sapienza" Battipaglia Italy
Allergologia e Immunologia Clinica, Azienda Ospedaliero-Universitaria di Cagliari Cagliari Italy
Struttura organizzativa Dipartimentale Complessa Immunologia e Terapie Cellulari, A.O.U. Careggi Florence Italy
Struttura complessa Allergologia Immunologia Clinica e Reumatologia.Azienda Socio Sanitaria Territoriale di Mantova Mantua Italy
Unità di Immunologia, Reumatologia, Allergologia e Malattie Rare all'IRCCS Ospedale San Raffaele di Milano Milan Italy
Division of Internal Medicine and Clinical Immunology, Azienda Ospedaliera Universitaria Federico II Naples Italy
SYNERGO - Institute of Clinical Immunotherapy and Advanced Biological Treatmets-Casa di Cura Pierangeli S.r.l. Pescara Italy
UO Immunoallergologia clinica, Azienda Ospedaliero Universitaria Pisana Pisa Italy
UOC di Medicina Interna e Nutrizione Clinica -Policlinico Umberto I Roma Italy
Reumatologia e Immunologia Clinica, Humanitas Research Hospital Rozzano Italy
UOC Clinica Immunologica e Reumatologica, A.O.U. San Giovanni di Dio e Ruggi d'Aragona Salerno Italy
SC (U.C.O.) Medicina Clinica Azienda Sanitaria Universitaria Giuliano Isontina (ASU GI) Trieste Italy
SCDU Immunologia e Allergologia AO Ordine Mauriziano, University of Turin Turin Italy
Medicina Interna B - Azienda Ospedaliera Universitaria Integrata Verona Italy

More Società Italiana di Allergologia, Asma e Immunologia Clinica trials in Italy

Italian Registry of Allergen ImmunoTherapy Recruiting
Severe Asthma Network Italy Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07175610 on ClinicalTrials.gov ↗ ← All trials in Italy